出血性脑卒中再出血的分析与临床研究

目的：对出血性脑卒中再出血及其临床治疗进行分析研究。方法69例出血性脑卒中再出血患者设为研究组，同期68例非再出血患者作为对照组，观察并比较分析两组患者神经功能缺损程度、日常生活活动能力、意识障碍程度及临床疗效等。结果研究组美国国立卫生研究院卒中量表（NIHSS）、日常生活活动能力量表（ADL）得分明显高于对照组，昏迷指数（GCS）低于对照组，对照组临床治疗情况明显优于研究组，差异具有统计学意义（P〈0.05）。结论临床治疗出血性脑卒中再出血应以预防为主，规范的治疗，适时手术和血压管理是防治再出血的关键。

Analysis and clinical research on hemorrhagic cerebral apoplexy rehaemorrhagia

Objective To analyze and study the clinical treatment on hemorrhagic cerebral apoplexy rehaemorrhagia.Methods A total of 69 cases of patients with hemorrhagic cerebral apoplexy rehaemorrhagia were contained in research group, and 68 cases of patients without rehaemorrhagia were contained in control group. Observation and comparison was made between the two groups on the degree of nervous functional defect, ability of daily life activities, disturbance of consciousness, and clinical curative effect.Results Scores of The National Institutes of Health Stroke Scale （NIHSS） and Activity of Daily Living Scale （ADL） in the research group were obviously higher than those in the control group. Score of Glasgow Coma Scale （GCS） in the research group is lower than that in the control group. The clinical treatment of the control group is better than the research group, and the difference had statistical significance （P〈0.05）.Conclusion Prevention treatment is the main method in treating hemorrhagic cerebral apoplexy rehaemorrhagia, and standard treatment, timely surgery and blood pressure management are key factors in preventing rehaemorrhagia.